Abstract:The Ubiquitin proteasome system (UPS), an essential eukaryotic/host/cellular post-translational modification (PTM), plays a critical role in the regulation of diverse cellular functions including regulation of protein stability, immune signaling, antiviral activity, as well as virus replication. Although UPS regulation of viral proteins may be utilized by the host as a defense mechanism to invade viruses, viruses may have adapted to take advantage of the host UPS. This system can be manipulated by viruses such as the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) to stimulate various steps of the viral replication cycle and facilitate pathogenesis, thereby causing the respiratory disease COVID-19. Many SARS-CoV-2 encoded proteins including open reading frame 3a (ORF3a), ORF6, ORF7a, ORF9b, and ORF10 interact with the host's UPS machinery, influencing host immune signaling and apoptosis. Moreover, SARS-CoV-2 encoded papain-like protease (PLpro) interferes with the host UPS to facilitate viral replication and to evade the host's immune system. These alterations in SARS-CoV-2 infected cells have been revealed by various proteomic studies, suggesting potential targets for clinical treatment. To provide insight into the underlying causes of COVID-19 and suggest possible directions for therapeutic interventions, this paper reviews the intricate relationship between SARS-CoV-2 and UPS. Promising treatment strategies are also investigated in this paper including targeting PLpro with zinc-ejector drugs, as well as targeting viral non-structural protein (nsp12) via heat treatment associated ubiquitin-mediated proteasomal degradation to reduce viral pathogenesis.

Regulation of SARS-CoV-2 Infection and Antiviral Innate Immunity by Ubiquitination and Ubiquitin-Like Conjugation

Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection

Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2

Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19

Elevated Ubiquitination Contributes to Protective Immunity Against Severe SARS‐CoV‐2 Infection

Fine-tuning of antiviral innate immunity by ubiquitination

The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses

Regulation of Cellular Antiviral Signaling by Modifications of Ubiquitin and Ubiquitin-like Molecules

Regulation of Innate Antiviral Immunity by Protein Ubiquitination

E3 ubiquitin ligases, the powerful modulator of innate antiviral immunity

SARS-CoV-2 and UPS with potentials for therapeutic interventions

ISGylation in Innate Antiviral Immunity and Pathogen Defense Responses: A Review

Advance in Research on the Regulation of Innate Immune Response by Ubiquitination

Dual-Role Ubiquitination Regulation Shuttling the Entire Life Cycle of the Flaviviridae

Cellular Deubiquitylating Enzyme: A Regulatory Factor of Antiviral Innate Immunity

E3 Ubiquitin Ligases: The Operators of the Ubiquitin Code That Regulates the RLR and cGAS-STING Pathways

The Mechanism of Glycosylation in SARS-CoV-2 Infection and Application in Drug Development

Regulation of cellular innate antiviral signaling by ubiquitin modification.

The Role of Deubiquitinases in Virus Replication and Host Innate Immune Response

Role of Virally-Encoded Deubiquitinating Enzymes in Regulation of the Virus Life Cycle

An expanded lexicon for the ubiquitin code